CentriMag Circulatory Support System
Abbott · Decision date Dec 6, 2019
What did the FDA approve?
FDA records P170038 as an original PMA application. The recorded decision is approval, dated Dec 6, 2019.
FDA approval order statement
Approval for temporary circulatory support for up to 30 days for one or both sides of the heart to treat postcardiotomy patients who fail to wean from cardiopulmonary bypass, providing a bridge to decision when it is unclear whether the patient's heart will recover or whether the patient will need alternative, longer-term therapy.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 6, 2019
Regulatory record facts
- Identifier
- P170038
- Regulatory pathway
- Premarket approval application
- Applicant
- Abbott
- Product code
- DSQ
- Decision code
- APPR
- Decision date
- Dec 6, 2019
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P170038 received
Application receipt date recorded by FDA.
P170038 · FDA decision
APPR
P170038/S032 · Related supplement
CentriMag Circulatory Support System
P170038/S033 · Related supplement
CentriMag Circulatory Support System
P170038/S034 · Related supplement
CentriMag Circulatory Support System
Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170038
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CentriMag Circulatory Support SystemP170038/S032 | Abbott | PMA supplement | Sep 2, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S033 | Abbott | PMA supplement | Oct 2, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
EXCOR Pediatric VADP160035/S056 | Berlin Heart, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 6035 Stoneridge Dr., Pleasanton, CA, 94588
Sources and methodology
- Original FDA record: P170038
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




